← SynDRA
DETOMIDINE
SynDRA canonical compound SYN0033476 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ADRA2A |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
| Indication | sedative |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- adrenergic receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- CP3A7
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Analgesics
- Central Nervous System Agents
- Central Nervous System Depressants
- Hypnotics and Sedatives
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sensory System Agents
Cross-references
Synonyms
- DORMOSEDAN
- Detomequin
- Detomised
- detomidine hydrochloride
- Detomidina
- 7N8K34P2XH
- Detomidinum
- RefChem:58521
- DTXCID00149948
- Detomidine (INN)
- DETOMIDINE [INN]
- Detomidine [INN:BAN]
- Detomidinum [INN-Latin]
- Detomidina [INN-Spanish]
- UNII-7N8K34P2XH
- NCGC00182057-02
- Dexdor (T)
- MFCD00864351
- DETOMIDINE [MI]
- SCHEMBL247340
- orb1704578
- SCHEMBL2626815
- SCHEMBL29833001
- HY-B0163
- EBC-43030
- MSK163512
- AKOS006271731
- AKOS040745170
- CS-1995
- SB38652
- NS00015400
- NS00134282
- D07795
- T22719
- AB01566879_01
- EN300-27192520
- SR-01000945281
- SR-01000945281-1
Look up DETOMIDINE in the interactive SynDRA portal →